SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors.Lancet Respir Med. 2020 Jun; 8(6):e50-e51.LR
Links
MeSH
Pub Type(s)
Letter
Language
eng
PubMed ID
32411576
Citation
Milne, Stephen, et al. "SARS-CoV-2 Receptor ACE2 Gene Expression and RAAS Inhibitors." The Lancet. Respiratory Medicine, vol. 8, no. 6, 2020, pp. e50-e51.
Milne S, Yang CX, Timens W, et al. SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors. Lancet Respir Med. 2020;8(6):e50-e51.
Milne, S., Yang, C. X., Timens, W., Bossé, Y., & Sin, D. D. (2020). SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors. The Lancet. Respiratory Medicine, 8(6), e50-e51. https://doi.org/10.1016/S2213-2600(20)30224-1
Milne S, et al. SARS-CoV-2 Receptor ACE2 Gene Expression and RAAS Inhibitors. Lancet Respir Med. 2020;8(6):e50-e51. PubMed PMID: 32411576.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors.
AU - Milne,Stephen,
AU - Yang,Chen Xi,
AU - Timens,Wim,
AU - Bossé,Yohan,
AU - Sin,Don D,
Y1 - 2020/05/13/
PY - 2020/4/6/received
PY - 2020/4/21/revised
PY - 2020/4/27/accepted
PY - 2020/5/16/pubmed
PY - 2020/7/1/medline
PY - 2020/5/16/entrez
SP - e50
EP - e51
JF - The Lancet. Respiratory medicine
JO - Lancet Respir Med
VL - 8
IS - 6
SN - 2213-2619
UR - https://www.unboundmedicine.com/medline/citation/32411576/SARS_CoV_2_receptor_ACE2_gene_expression_and_RAAS_inhibitors_
DB - PRIME
DP - Unbound Medicine
ER -